Recent Finacing
Recent Raise
Inform Genomics develops a personalized medicine platform and ONPART™, a molecular diagnostic predicting patients' risk of common chemotherapy side effects for colorectal, breast, lung, prostate, and ovarian cancers.
Focus Areas
Funding round